{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T09:49:08Z","timestamp":1760521748609,"version":"3.37.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270664"],"award-info":[{"award-number":["82270664"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Project of Xiamen Cell Therapy Research, Xiamen, Fujian, China","award":["3502Z20214001"],"award-info":[{"award-number":["3502Z20214001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>The tumor microenvironment (TME) in cholangiocarcinoma (CHOL) is typically characterized by a low level of immune infiltration, which accounts for the dismal prognosis of this patient population. This study sought to investigate the mechanisms underlying the reduced infiltration of immune cells into the CHOL TME.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We constructed a Least Absolute Shrinkage and Selection Operator (LASSO) regression model to identify prognosis-related differentially expressed genes (DEGs). The 'Corrplot' package was employed to analyze the correlation between dermatopontin (DPT) and immune infiltration in CHOL. The Tumor and Immune System Interaction Database (TISIDB) was used to evaluate the association between DPT and immunology. Single-cell analysis was conducted to localize CCL19 secretions. Western blot and qPCR were utilized to detect DPT expression, while immunofluorescence was performed to investigate the cellular localization of DPT. Additionally, ELISA analysis was employed to assess the alteration in CCL19 secretion in cancer-associated fibroblasts (CAFs) and macrophages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Our findings revealed that CHOL patients with low DPT expression had a poorer prognosis. Enrichment analysis demonstrated a positive correlation between DPT levels and the infiltration of immunomodulators and immune cells. Moreover, high DPT levels were associated with enhanced anti-PD-1\/PD-L1 immunotherapeutic responses. Furthermore, DPT expression impacted the landscape of gene mutations, showing a negative association with tumor grade, stage, and lymph node metastasis. Based on the results of protein peptides analysis and cell experiments, it was inferred that the downregulation of DPT in CHOL cells effectively suppressed the secretion of CCL19 in macrophages.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>DPT is a novel prognosis-related biomarker for CHOL patients, and this study provides preliminary insights into the mechanism by which DPT promotes the infiltration of immune cells into the CHOL TME.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-023-05532-1","type":"journal-article","created":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T14:02:25Z","timestamp":1706796145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Downregulation of dermatopontin in cholangiocarcinoma cells suppresses CCL19 secretion of macrophages and immune infiltration"],"prefix":"10.1007","volume":"150","author":[{"given":"Peng","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoxuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donghua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,2,1]]},"reference":[{"key":"5532_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23169222","author":"V Catal\u00e1n","year":"2022","unstructured":"Catal\u00e1n V, Domench P, G\u00f3mez-Ambrosi J, Ram\u00edrez B, Becerril S, Mentxaka A, Rodr\u00edguez A, Valent\u00ed V, Moncada R, Baixauli J, Silva C, Escalada J, Fr\u00fchbeck G (2022) Dermatopontin influences the development of obesity-associated colon cancer by changes in the expression of extracellular matrix proteins. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23169222","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5532_CR2","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jaci.2017.12.998","volume":"142","author":"HW Cheng","year":"2018","unstructured":"Cheng HW, Onder L, Cupovic J, Boesch M, Novkovic M, Pikor N, Tarantino I, Rodriguez R, Schneider T, Jochum W, Brutsche M, Ludewig B (2018) CCL19-producing fibroblastic stromal cells restrain lung carcinoma growth by promoting local antitumor T-cell responses. J Allergy Clin Immunol 142(4):1257-1271.e1254. https:\/\/doi.org\/10.1016\/j.jaci.2017.12.998","journal-title":"J Allergy Clin Immunol"},{"issue":"18","key":"5532_CR3","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/nejm199910283411807","volume":"341","author":"PC de Groen","year":"1999","unstructured":"de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Engl J Med 341(18):1368\u20131378. https:\/\/doi.org\/10.1056\/nejm199910283411807","journal-title":"N Engl J Med"},{"key":"5532_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cells10020223","author":"MV Dieci","year":"2021","unstructured":"Dieci MV, Miglietta F, Guarneri V (2021) Immune infiltrates in breast cancer: recent updates and clinical implications. Cells. https:\/\/doi.org\/10.3390\/cells10020223","journal-title":"Cells"},{"issue":"5","key":"5532_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4065\/70.5.425","volume":"70","author":"DR Farley","year":"1995","unstructured":"Farley DR, Weaver AL, Nagorney DM (1995) \u201cNatural history\u201d of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 70(5):425\u2013429. https:\/\/doi.org\/10.4065\/70.5.425","journal-title":"Mayo Clin Proc"},{"key":"5532_CR6","doi-asserted-by":"publisher","unstructured":"Fu Y, Feng MX, Yu J, Ma MZ, Liu XJ, Li J, Yang XM, Wang YH, Zhang YL, Ao JP, Xue F, Qin W, Gu J, Xia Q, Zhang ZG (2014) DNA methylation-mediated silencing of matricellular protein dermatopontin promotes hepatocellular carcinoma metastasis by \u03b13\u03b21 integrin-Rho GTPase signaling. Oncotarget 5(16):6701\u20136715. https:\/\/doi.org\/10.18632\/oncotarget.2239","DOI":"10.18632\/oncotarget.2239"},{"key":"5532_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/biom10081087","author":"T Fujimura","year":"2020","unstructured":"Fujimura T, Aiba S (2020) Significance of immunosuppressive cells as a target for immunotherapies in melanoma and non-melanoma skin cancers. Biomolecules. https:\/\/doi.org\/10.3390\/biom10081087","journal-title":"Biomolecules"},{"key":"5532_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.mce.2018.10.021","volume":"480","author":"Y Guo","year":"2019","unstructured":"Guo Y, Li H, Guan H, Ke W, Liang W, Xiao H, Li Y (2019) Dermatopontin inhibits papillary thyroid cancer cell proliferation through MYC repression. Mol Cell Endocrinol 480:122\u2013132. https:\/\/doi.org\/10.1016\/j.mce.2018.10.021","journal-title":"Mol Cell Endocrinol"},{"issue":"8","key":"5532_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2023.105021","volume":"299","author":"JM Hogstrom","year":"2023","unstructured":"Hogstrom JM, Cruz KA, Selfors LM, Ward MN, Mehta TS, Kanarek N, Philips J, Dialani V, Wulf G, Collins LC, Patel JM, Muranen T (2023) Simultaneous isolation of hormone receptor-positive breast cancer organoids and fibroblasts reveals stroma-mediated resistance mechanisms. J Biol Chem 299(8):105021. https:\/\/doi.org\/10.1016\/j.jbc.2023.105021","journal-title":"J Biol Chem"},{"issue":"5","key":"5532_CR10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3892\/ol.2021.12669","volume":"21","author":"H Huang","year":"2021","unstructured":"Huang H, Hao Z, Long L, Yin Z, Wu C, Zhou X, Zhang B (2021) Dermatopontin as a potential pathogenic factor in endometrial cancer. Oncol Lett 21(5):408. https:\/\/doi.org\/10.3892\/ol.2021.12669","journal-title":"Oncol Lett"},{"key":"5532_CR11","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000582","author":"Y Iida","year":"2020","unstructured":"Iida Y, Yoshikawa R, Murata A, Kotani H, Kazuki Y, Oshimura M, Matsuzaki Y, Harada M (2020) Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells. J Immunother Cancer. https:\/\/doi.org\/10.1136\/jitc-2020-000582","journal-title":"J Immunother Cancer"},{"key":"5532_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells8040332","author":"T Kim","year":"2019","unstructured":"Kim T, Ahmad K, Shaikh S, Jan AT, Seo MG, Lee EJ, Choi I (2019) Dermatopontin in skeletal muscle extracellular matrix regulates myogenesis. Cells. https:\/\/doi.org\/10.3390\/cells8040332","journal-title":"Cells"},{"issue":"18","key":"5532_CR13","doi-asserted-by":"publisher","first-page":"3609","DOI":"10.1182\/bloodadvances.2021004475","volume":"5","author":"AC Kramer","year":"2021","unstructured":"Kramer AC, Astuti Y, Elfstrum A, Lehrke MJ, Tolar J, Blazar BR, Blake AL, Taisto ME, Furcich JW, Nolan EE, Durose WW, Webber BR, Geisness A, Wood DK, Lund TC (2021) An irradiated marrow niche reveals a small noncollagenous protein mediator of homing, dermatopontin. Blood Adv 5(18):3609\u20133622. https:\/\/doi.org\/10.1182\/bloodadvances.2021004475","journal-title":"Blood Adv"},{"issue":"21","key":"5532_CR14","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.7150\/jca.47157","volume":"11","author":"S Liu","year":"2020","unstructured":"Liu S, Qiu J, He G, Geng C, He W, Liu C, Cai D, Pan H, Tian Q (2020) Dermatopontin inhibits WNT signaling pathway via CXXC finger protein 4 in hepatocellular carcinoma. J Cancer 11(21):6288\u20136298. https:\/\/doi.org\/10.7150\/jca.47157","journal-title":"J Cancer"},{"key":"5532_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.874056","volume":"13","author":"F Liu","year":"2022","unstructured":"Liu F, Wang P, Sun W, Jiang Y, Gong Q (2022) Identification of ligand-receptor pairs associated with tumour characteristics in clear cell renal cell carcinoma. Front Immunol 13:874056. https:\/\/doi.org\/10.3389\/fimmu.2022.874056","journal-title":"Front Immunol"},{"issue":"1","key":"5532_CR16","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1186\/s40425-019-0814-7","volume":"7","author":"J Ma","year":"2019","unstructured":"Ma J, Zheng B, Goswami S, Meng L, Zhang D, Cao C, Li T, Zhu F, Ma L, Zhang Z, Zhang S, Duan M, Chen Q, Gao Q, Zhang X (2019) PD1(Hi) CD8(+) T cells correlate with exhausted signature and poor clinical outcome in hepatocellular carcinoma. J Immunother Cancer 7(1):331. https:\/\/doi.org\/10.1186\/s40425-019-0814-7","journal-title":"J Immunother Cancer"},{"issue":"26","key":"5532_CR17","doi-asserted-by":"publisher","first-page":"19826","DOI":"10.1016\/S0021-9258(19)36588-3","volume":"268","author":"JR MacBeath","year":"1993","unstructured":"MacBeath JR, Shackleton DR, Hulmes DJ (1993) Tyrosine-rich acidic matrix protein (TRAMP) accelerates collagen fibril formation in vitro. J Biol Chem 268(26):19826\u201319832","journal-title":"J Biol Chem"},{"issue":"9","key":"5532_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri.2017.49","volume":"17","author":"N Nagarsheth","year":"2017","unstructured":"Nagarsheth N, Wicha MS, Zou W (2017) Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy. Nat Rev Immunol 17(9):559\u2013572. https:\/\/doi.org\/10.1038\/nri.2017.49","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5532_CR19","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1080\/03008200600846564","volume":"47","author":"O Okamoto","year":"2006","unstructured":"Okamoto O, Fujiwara S (2006) Dermatopontin, a novel player in the biology of the extracellular matrix. Connect Tissue Res 47(4):177\u2013189. https:\/\/doi.org\/10.1080\/03008200600846564","journal-title":"Connect Tissue Res"},{"issue":"1","key":"5532_CR20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13045-021-01128-9","volume":"14","author":"N Pang","year":"2021","unstructured":"Pang N, Shi J, Qin L, Chen A, Tang Y, Yang H, Huang Y, Wu Q, Li X, He B, Li T, Liang B, Zhang J, Cao B, Liu M, Feng Y, Ye X, Chen X, Wang L et al (2021) IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin. J Hematol Oncol 14(1):118. https:\/\/doi.org\/10.1186\/s13045-021-01128-9","journal-title":"J Hematol Oncol"},{"issue":"4","key":"5532_CR21","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/j.fertnstert.2015.12.021","volume":"105","author":"A Patel","year":"2016","unstructured":"Patel A, Malik M, Britten J, Cox J, Catherino WH (2016) Mifepristone inhibits extracellular matrix formation in uterine leiomyoma. Fertil Steril 105(4):1102\u20131110. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.12.021","journal-title":"Fertil Steril"},{"issue":"3","key":"5532_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ (2019) Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov 18(3):175\u2013196. https:\/\/doi.org\/10.1038\/s41573-018-0006-z","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"5532_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/annonc\/mdu450","volume":"26","author":"R Salgado","year":"2015","unstructured":"Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G et al (2015) The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol 26(2):259\u2013271. https:\/\/doi.org\/10.1093\/annonc\/mdu450","journal-title":"Ann Oncol"},{"issue":"11","key":"5532_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242798","volume":"15","author":"TM Seetaraman Amritha","year":"2020","unstructured":"Seetaraman Amritha TM, Mahajan S, Subramaniam K, Chandramohan Y, Dhanasekaran A (2020) Cloning, expression and purification of recombinant dermatopontin in Escherichia coli. PLoS ONE 15(11):e0242798. https:\/\/doi.org\/10.1371\/journal.pone.0242798","journal-title":"PLoS ONE"},{"issue":"15","key":"5532_CR25","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1158\/0008-5472.Can-04-0240","volume":"64","author":"A Somasiri","year":"2004","unstructured":"Somasiri A, Nielsen JS, Makretsov N, McCoy ML, Prentice L, Gilks CB, Chia SK, Gelmon KA, Kershaw DB, Huntsman DG, McNagny KM, Roskelley CD (2004) Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progression. Cancer Res 64(15):5068\u20135073. https:\/\/doi.org\/10.1158\/0008-5472.Can-04-0240","journal-title":"Cancer Res"},{"issue":"3","key":"5532_CR26","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1046\/j.1523-1747.2002.01863.x","volume":"119","author":"U Takeda","year":"2002","unstructured":"Takeda U, Utani A, Wu J, Adachi E, Koseki H, Taniguchi M, Matsumoto T, Ohashi T, Sato M, Shinkai H (2002) Targeted disruption of dermatopontin causes abnormal collagen fibrillogenesis. J Invest Dermatol 119(3):678\u2013683. https:\/\/doi.org\/10.1046\/j.1523-1747.2002.01863.x","journal-title":"J Invest Dermatol"},{"issue":"2","key":"5532_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1677\/joe.1.06619","volume":"190","author":"T Takeuchi","year":"2006","unstructured":"Takeuchi T, Suzuki M, Kumagai J, Kamijo T, Sakai M, Kitamura T (2006) Extracellular matrix dermatopontin modulates prostate cell growth in vivo. J Endocrinol 190(2):351\u2013361. https:\/\/doi.org\/10.1677\/joe.1.06619","journal-title":"J Endocrinol"},{"key":"5532_CR28","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax0182","author":"SL Topalian","year":"2020","unstructured":"Topalian SL, Taube JM, Pardoll DM (2020) Neoadjuvant checkpoint blockade for cancer immunotherapy. Science. https:\/\/doi.org\/10.1126\/science.aax0182","journal-title":"Science"},{"key":"5532_CR29","doi-asserted-by":"publisher","unstructured":"Unamuno X, G\u00f3mez-Ambrosi J, Ram\u00edrez B, Rodr\u00edguez A, Becerril S, Valent\u00ed V, Moncada R, Silva C, Salvador J, Fr\u00fchbeck G, Catal\u00e1n V (2020) Dermatopontin, a novel adipokine promoting adipose tissue extracellular matrix remodelling and inflammation in obesity. J Clin Med. https:\/\/doi.org\/10.3390\/jcm9041069","DOI":"10.3390\/jcm9041069"},{"issue":"10","key":"5532_CR30","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1158\/2326-6066.Cir-17-0171","volume":"5","author":"MP Velasquez","year":"2017","unstructured":"Velasquez MP, Szoor A, Vaidya A, Thakkar A, Nguyen P, Wu MF, Liu H, Gottschalk S (2017) CD28 and 41BB costimulation enhances the effector function of CD19-specific engager T cells. Cancer Immunol Res 5(10):860\u2013870. https:\/\/doi.org\/10.1158\/2326-6066.Cir-17-0171","journal-title":"Cancer Immunol Res"},{"key":"5532_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.869768","volume":"13","author":"KM Viramontes","year":"2022","unstructured":"Viramontes KM, Neubert EN, DeRogatis JM, Tinoco R (2022) PD-1 immune checkpoint blockade and PSGL-1 inhibition synergize to reinvigorate exhausted T cells. Front Immunol 13:869768. https:\/\/doi.org\/10.3389\/fimmu.2022.869768","journal-title":"Front Immunol"},{"key":"5532_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108039","volume":"99","author":"Z Wang","year":"2021","unstructured":"Wang Z, Du Y (2021) Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining. Int Immunopharmacol 99:108039. https:\/\/doi.org\/10.1016\/j.intimp.2021.108039","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"5532_CR33","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/s41467-019-14046-9","volume":"11","author":"G Wang","year":"2020","unstructured":"Wang G, Xu J, Zhao J, Yin W, Liu D, Chen W, Hou SX (2020) Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat Commun 11(1):220. https:\/\/doi.org\/10.1038\/s41467-019-14046-9","journal-title":"Nat Commun"},{"issue":"12","key":"5532_CR34","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1093\/jnci\/djj234","volume":"98","author":"TM Welzel","year":"2006","unstructured":"Welzel TM, McGlynn KA, Hsing AW, O\u2019Brien TR, Pfeiffer RM (2006) Impact of classification of hilar cholangiocarcinomas (Klatskin tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 98(12):873\u2013875. https:\/\/doi.org\/10.1093\/jnci\/djj234","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"5532_CR35","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3892\/mmr.2017.7866","volume":"17","author":"LC Xi","year":"2018","unstructured":"Xi LC, Ji YX, Yin D, Zhao ZX, Huang SC, Yu SL, Liu BY, Li HY (2018) Effects of Dermatopontin gene silencing on apoptosis and proliferation of osteosarcoma MG-63 cells. Mol Med Rep 17(1):422\u2013427. https:\/\/doi.org\/10.3892\/mmr.2017.7866","journal-title":"Mol Med Rep"},{"issue":"10","key":"5532_CR36","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41419-018-1010-2","volume":"9","author":"Z Xu","year":"2018","unstructured":"Xu Z, Zhu C, Chen C, Zong Y, Feng H, Liu D, Feng W, Zhao J, Lu A (2018) CCL19 suppresses angiogenesis through promoting miR-206 and inhibiting Met\/ERK\/Elk-1\/HIF-1\u03b1\/VEGF-A pathway in colorectal cancer. Cell Death Dis 9(10):974. https:\/\/doi.org\/10.1038\/s41419-018-1010-2","journal-title":"Cell Death Dis"},{"issue":"1","key":"5532_CR37","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1189\/jlb.1A0314-170R","volume":"97","author":"W Xuan","year":"2015","unstructured":"Xuan W, Qu Q, Zheng B, Xiong S, Fan GH (2015) The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol 97(1):61\u201369. https:\/\/doi.org\/10.1189\/jlb.1A0314-170R","journal-title":"J Leukoc Biol"},{"issue":"6","key":"5532_CR38","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1007\/s00018-022-04339-6","volume":"79","author":"A Yamaji-Hasegawa","year":"2022","unstructured":"Yamaji-Hasegawa A, Murate M, Inaba T, Dohmae N, Sato M, Fujimori F, Sako Y, Greimel P, Kobayashi T (2022) A novel sterol-binding protein reveals heterogeneous cholesterol distribution in neurite outgrowth and in late endosomes\/lysosomes. Cell Mol Life Sci 79(6):324. https:\/\/doi.org\/10.1007\/s00018-022-04339-6","journal-title":"Cell Mol Life Sci"},{"issue":"12","key":"5532_CR39","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1002\/ijc.26328","volume":"130","author":"M Yamatoji","year":"2012","unstructured":"Yamatoji M, Kasamatsu A, Kouzu Y, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K (2012) Dermatopontin: a potential predictor for metastasis of human oral cancer. Int J Cancer 130(12):2903\u20132911. https:\/\/doi.org\/10.1002\/ijc.26328","journal-title":"Int J Cancer"},{"issue":"2","key":"5532_CR40","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41419-023-05657-8","volume":"14","author":"D Ye","year":"2023","unstructured":"Ye D, Wang Y, Deng X, Zhou X, Liu D, Zhou B, Zheng W, Wang X, Fang L (2023) DNMT3a-dermatopontin axis suppresses breast cancer malignancy via inactivating YAP. Cell Death Dis 14(2):106. https:\/\/doi.org\/10.1038\/s41419-023-05657-8","journal-title":"Cell Death Dis"},{"issue":"Suppl 1","key":"5532_CR41","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1016\/j.thromres.2021.12.027","volume":"213","author":"E Yeini","year":"2022","unstructured":"Yeini E, Satchi-Fainaro R (2022) The role of P-selectin in cancer-associated thrombosis and beyond. Thromb Res 213(Suppl 1):S22-s28. https:\/\/doi.org\/10.1016\/j.thromres.2021.12.027","journal-title":"Thromb Res"},{"issue":"4","key":"5532_CR42","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.kint.2017.03.030","volume":"92","author":"V Zavvos","year":"2017","unstructured":"Zavvos V, Buxton AT, Evans C, Lambie M, Davies SJ, Topley N, Wilkie M, Summers A, Brenchley P, Goumenos DS, Johnson TS (2017) A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent. Kidney Int 92(4):988\u20131002. https:\/\/doi.org\/10.1016\/j.kint.2017.03.030","journal-title":"Kidney Int"},{"issue":"8","key":"5532_CR43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17(8):807\u2013821. https:\/\/doi.org\/10.1038\/s41423-020-0488-6","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"5532_CR44","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s13577-020-00375-1","volume":"33","author":"R Zhou","year":"2020","unstructured":"Zhou R, Sun J, He C, Huang C, Yu H (2020) CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19\/CCR7\/AIM2 pathway. Hum Cell 33(4):1120\u20131132. https:\/\/doi.org\/10.1007\/s13577-020-00375-1","journal-title":"Hum Cell"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05532-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05532-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T13:08:10Z","timestamp":1711112890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05532-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["5532"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05532-1","relation":{},"ISSN":["1432-1335"],"issn-type":[{"type":"electronic","value":"1432-1335"}],"subject":[],"published":{"date-parts":[[2024,2,1]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by the Ethics Committees of The First Affiliated Hospital of Xiamen University (Xiamen, China) (The IRB approval number: XMYY-2022KYSB003).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All study participants gave their informed consent after being fully informed. The patients have given their written, informed consent for this paper's publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"66"}}